Performance Evaluation of Different Daily Disposable Multifocal Contact Lenses

December 6, 2023 updated by: Coopervision, Inc.
The objective of the study is to compare the lens performance of two daily disposable multifocal contact lenses.

Study Overview

Detailed Description

This is a prospective, randomized, participant-masked, crossover, bilateral dispensing study. Each lens type will be worn for approximately 3-4 weeks: the lens prescription of each lens type will be optimized after 3-8 days wearing experience, prior to starting a 2-week (14-21 day) wear period.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M2N 3A1
        • Eyes on Sheppard Clinic
      • Toronto, Ontario, Canada, M5V 3E7
        • Spadina Optometry
    • New York
      • Vestal, New York, United States, 13850
        • Sacco Eye Group PLLC
    • Ohio
      • Athens, Ohio, United States, 45701
        • Athens Eye Care- Dr. Shane Foster & Associates
    • Texas
      • Bellaire, Texas, United States, 77401
        • Bellaire Family Eye Care

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

42 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Is at least 42 years of age and has full legal capacity to volunteer;
  • Has read and signed an information consent letter;
  • Self reports having a full eye examination in the previous two years;
  • Anticipates being able to wear the study lenses for at least 8 hours a day, 5 days a week;
  • Is willing and able to follow instructions and maintain the appointment schedule;
  • Habitually wears multifocal soft contact lenses, for the past 3 months minimum^;

    • Maximum of 7 participants per site should be habitual wearers of daily disposable lenses

      • Maximum of 3 habitual wearers per site of 1-Day Acuvue Moist Multifocal
      • Maximum of 1 habitual wearer per site of ACUVUE OASYS MAX 1-Day MULTIFOCAL
      • Maximum of 3 habitual wearers per site of MyDay Multifocal
    • Maximum of 7 participants per site should be habitual wearers of frequent replacement lenses

      • Maximum of 1 habitual wearer per site of ACUVUE OASYS for PRESBYOPIA
  • Has refractive astigmatism no higher than -0.75DC;
  • Is presbyopic and requires a reading addition of at least +0.75D and no more than +2.50D;
  • Can be fit and achieve binocular distance vision of at least 20/30 Snellen (or +0.20 logMAR) which participants also deem to be 'acceptable', with the available study lens parameters (Distance sphere +4 to -6; near addition as per study design).

Exclusion Criteria:

  • Is participating in any concurrent clinical or research trial;
  • Has any known active* ocular disease and/or infection that contraindicates contact lens wear;
  • Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;
  • Is using any systemic or topical medications that in the opinion of the investigator may affect contact lens wear or a study outcome variable;
  • Has known sensitivity to the diagnostic sodium fluorescein used in the study;
  • Self-reports as pregnant, lactating or planning a pregnancy at the time of enrolment;
  • Has undergone refractive error surgery or intraocular surgery.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Control Contact Lens, Then Test Contact Lens
Participants will wear control contact lenses for two weeks and then crossover to test contact lenses for two weeks.
two weeks of wear
two weeks of wear
Experimental: Test Contact Lens, Then Control Contact Lens
Participants will wear test contact lenses for two weeks and then crossover to control contact lenses for two weeks.
two weeks of wear
two weeks of wear

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lens Handling for Removal
Time Frame: 2 weeks of wear
Lens Handling for Removal, using a 0-100 scale (0=Very difficult, 100=Very easy)
2 weeks of wear

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Fiona Soong, Eyes on Sheppard Clinic
  • Principal Investigator: David Wilkinson, Spadina Optometry
  • Principal Investigator: Ashley Tucker, Bellaire Family Eye Care
  • Principal Investigator: Shane Foster, Athens Eye Care - Dr. Shane Foster & Associates
  • Principal Investigator: Andrew Sacco, Sacco Eye Group PLLC

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 10, 2022

Primary Completion (Actual)

June 15, 2023

Study Completion (Actual)

June 15, 2023

Study Registration Dates

First Submitted

February 21, 2023

First Submitted That Met QC Criteria

March 9, 2023

First Posted (Actual)

March 10, 2023

Study Record Updates

Last Update Posted (Estimated)

December 7, 2023

Last Update Submitted That Met QC Criteria

December 6, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EX-MKTG-144

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Presbyopia

Clinical Trials on Control Contact Lens (stenfilcon A Daily Disposable Multifocal Contact Lens)

3
Subscribe